Clinical trial
The Safety and Efficacy of Fluoxetine for Treatment of Refractory Constipation
NCT06750445 is registered in ClinicalTrials.gov with Zhifeng Zhao, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Fluoxetine for Treatment of Refractory Constipation
- Lead sponsor
- Zhifeng Zhao, PhD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- May 30, 2025
- Enrollment
- 316 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
refractory constipation